lopinavir has been researched along with Malaria, Falciparum in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caffarena, ER; Cunico, W; da Silva, FS; de Magalhães, CS; Facchinetti, V; Gomes, CR; Henriques, MG; Krettli, AU; Krettli, LG; Moreth, M; Penido, C; Varotti, FP | 1 |
| Aweeka, F; Ehrlich, H; Freeman, T; French, J; Goodwin, J; Huang, L; Kajubi, R; Kay, K; Li, F; Mwebaza, N; Ou, J; Parikh, S; Riggs, M; Ruiz-Garcia, A; Wade, M; Wang, K | 1 |
| Borkowsky, W; Duffy, PE; Hobbs, CV; Muratova, O; Tanaka, TQ; Van Vliet, J; Williamson, KC | 1 |
| Borkowsky, W; De La Vega, P; Duffy, PE; Hobbs, CV; Krzych, U; Penzak, SR; Sinnis, P; Van Vliet, J | 1 |
| Borkowsky, W; Chakravarty, S; Chen, J; Conteh, S; Donnelly, L; Duffy, PE; Healy, S; Hinderer, J; Hobbs, CV; Hoffman, SL; Lambert, L; Marsh, K; Neal, J; Orr-Gonzalez, S; Penzak, SR | 1 |
| Barlow-Mosha, L; Borkowsky, W; Chen, J; Chi, BH; Deygoo, N; Duffy, PE; Gabriel, EE; Hobbs, CV; Ilmet, T; Jean Philippe, P; Kamthunzi, P; Kirmse, B; Li, Y; Mofenson, L; Musoke, P; Neal, J; Palumbo, P; Parikh, S; Petzold, E; Prescott, W; Tauzie, J; Tegha, G | 1 |
| Butterworth, AS; Gardiner, DL; Kirk, K; Martin, RE; McCarthy, JS; Skinner-Adams, TS | 1 |
| Goldstein, JA; Kroetz, DL; Ouedraogo, JB; Parikh, S; Rosenthal, PJ | 1 |
| Andrews, KT; Gardiner, DL; Kelly, M; McCarthy, JS; Ray, J; Redmond, AM; Skinner-Adams, T | 1 |
1 trial(s) available for lopinavir and Malaria, Falciparum
| Article | Year |
|---|---|
Malaria in HIV-Infected Children Receiving HIV Protease-Inhibitor- Compared with Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy, IMPAACT P1068s, Substudy to P1060.
Topics: Antimalarials; CD4 Lymphocyte Count; Child; Child, Preschool; Coinfection; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Infant; Lamivudine; Lopinavir; Malaria, Falciparum; Malawi; Male; Nevirapine; Plasmodium falciparum; Reverse Transcriptase Inhibitors; Ritonavir; Viral Load; Zidovudine | 2016 |
9 other study(ies) available for lopinavir and Malaria, Falciparum
| Article | Year |
|---|---|
Synthesis, antimalarial evaluation and molecular modeling studies of hydroxyethylpiperazines, potential aspartyl protease inhibitors, part 2.
Topics: Animals; Antimalarials; Aspartic Acid Endopeptidases; Cell Line; Erythrocytes; Ethanolamines; Humans; Macrophages; Malaria, Falciparum; Models, Molecular; Monocytes; Murinae; Plasmodium falciparum; Protein Binding; Protozoan Proteins | 2009 |
Impact of Drug Exposure on Resistance Selection Following Artemether-Lumefantrine Treatment for Malaria in Children With and Without HIV in Uganda.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Drug Combinations; Fluorenes; HIV Infections; Humans; Lopinavir; Lumefantrine; Malaria; Malaria, Falciparum; Nevirapine; Ritonavir; Uganda | 2023 |
HIV treatments have malaria gametocyte killing and transmission blocking activity.
Topics: Animals; Anopheles; Anti-HIV Agents; Antimalarials; Dose-Response Relationship, Drug; HIV Protease Inhibitors; Humans; Lopinavir; Malaria, Falciparum; Nevirapine; Plasmodium falciparum; Reverse Transcriptase Inhibitors; Saquinavir; Trimethoprim, Sulfamethoxazole Drug Combination | 2013 |
The effect of antiretrovirals on Plasmodium falciparum liver stages.
Topics: HIV Infections; HIV Protease Inhibitors; Humans; In Vitro Techniques; Liver; Lopinavir; Malaria, Falciparum; Nevirapine; Plasmodium falciparum; Reverse Transcriptase Inhibitors; Saquinavir | 2013 |
HIV treatments reduce malaria liver stage burden in a non-human primate model of malaria infection at clinically relevant concentrations in vivo.
Topics: Animals; Antimalarials; Disease Models, Animal; Drug Combinations; HIV Protease Inhibitors; Liver; Lopinavir; Macaca mulatta; Malaria, Falciparum; Plasmodium falciparum; Ritonavir; Sulfadoxine; Trimethoprim | 2014 |
Saquinavir inhibits the malaria parasite's chloroquine resistance transporter.
Topics: Animals; Antimalarials; Biological Transport; Chloroquine; Drug Combinations; Drug Synergism; Female; HIV Protease Inhibitors; Humans; Lopinavir; Malaria, Falciparum; Membrane Transport Proteins; Mutation; Oocytes; Plasmodium falciparum; Protozoan Proteins; Ritonavir; Saquinavir; Tritium; Xenopus laevis | 2012 |
ART regimen protects children from malaria.
Topics: Child; Drug Combinations; HIV Infections; HIV Protease Inhibitors; Humans; Lopinavir; Malaria, Falciparum; Reverse Transcriptase Inhibitors; Ritonavir | 2012 |
Amodiaquine metabolism is impaired by common polymorphisms in CYP2C8: implications for malaria treatment in Africa.
Topics: Alkynes; Amodiaquine; Antimalarials; Aryl Hydrocarbon Hydroxylases; Benzoxazines; Burkina Faso; Chromatography, High Pressure Liquid; Cyclopropanes; Cytochrome P-450 CYP2C8; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Genotype; HIV Protease Inhibitors; Humans; Lopinavir; Malaria, Falciparum; Models, Biological; Polymorphism, Genetic; Pyridines; Pyrimidinones; Pyrones; Reverse Transcriptase Inhibitors; Saquinavir; Spectrophotometry, Ultraviolet; Sulfonamides; Treatment Outcome; Trimethoprim | 2007 |
Antimalarial activity of sera from subjects taking HIV protease inhibitors.
Topics: Animals; Antimalarials; Antiretroviral Therapy, Highly Active; Chloroquine; Drug Synergism; HIV Infections; HIV Protease Inhibitors; Humans; Lopinavir; Malaria, Falciparum; Plasmodium falciparum; Pyrimidinones; Reverse Transcriptase Inhibitors; Ritonavir; Saquinavir; Treatment Outcome | 2007 |